Investors

Motif Bio is a clinical stage biopharmaceutical company which specializes in developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. Iclaprim is being developed for the treatment of the most common and serious bacterial infections... Read More

Stock Quote

MTFB (ADS)$8.20 Stock is Up 0.02 (0.24%)
Volume5,470
Today's Open$8.11
Previous Close$8.18
Data as of September 19, 2017 3:56 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.Learn More

Presentations

Upcoming Events

Motif Biosciences Inc Investor and Analyst Event
Wednesday, September 20, 2017 8:00 a.m. ET
Learn More